Caplin Point Laboratories Limited Share Price & Analysis
₹2,608▼ -1.56%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹2,608
-1.56%
Open
₹—
High
₹2,661.8
Low
₹2,606
Close
₹2,608
52W High
₹2,700
52W Low
₹1,500
Volume
53K
Lot Size
1
Sector
Healthcare
Market Cap
₹20K Cr
Face Value
₹2
Mid CapNIFTY 500
Price Chart
Fundamentals
P/E
31
Sector P/E
54.4
P/B
4.3
EPS
₹84.15
ROE
20.6%
ROCE
24.6%
D/E Ratio
0
Div Yield
0.23%
Book Value
₹472
+
Strengths
- ✓Excellent return on equity (ROE 20.6%)
- ✓Efficient capital deployment (ROCE 24.6%)
- ✓Attractively valued vs sector (P/E 31x vs industry 54.4x)
- ✓Virtually debt-free
−
Concerns
- ✗Trading near 52-week high (₹2,700)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
CAPLIPOINT · as of Mar 2026
Promoters70.56%
FII5.73%▲0.87
DII2.00%▼0.11
Public21.72%▼0.76
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 70.62% | 70.62% | 70.56% | 70.56% | 70.56% | 70.56% |
| FII | 2.84% | 3.33% | 3.38% | 3.71% | 4.86% | 5.73% |
| DII | 0.43% | 1.08% | 1.49% | 1.83% | 2.11% | 2.00% |
| Public | 26.11% | 24.95% | 24.59% | 23.93% | 22.48% | 21.72% |
Corporate Events
Interim Dividend - Rs 4 Per Share
Record: 29 May 2026
Dividend28 May 2026
Dividend - Rs 3 Per Share
Dividend11 Sept 2025
Interim Dividend - Rs 3 Per Share
Dividend29 May 2025
Dividend - Rs 2.50 Per Share
Dividend22 Sept 2024
Annual General Meeting
AGM22 Sept 2024
Interim Dividend - Rs 2.50 Per Share
Dividend30 May 2024
Annual General Meeting/Dividend - Rs 2.50 Per Share
Dividend13 Sept 2023
Interim Dividend - Rs 2 Per Share
Dividend8 Jun 2023
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹600 Cr ▲10.5% | ₹543 Cr ▲1.7% | ₹534 Cr ▲4.7% | ₹510 Cr ▲1.6% | ₹502 Cr ▲1.8% | ₹493 Cr ▲2.1% | ₹483 Cr ▲5.2% | ₹459 Cr |
| Op. Profit | ₹204 Cr ▲7.4% | ₹190 Cr ▲0.5% | ₹189 Cr ▲6.2% | ₹178 Cr ▲6.0% | ₹168 Cr ▲3.7% | ₹162 Cr ▼1.8% | ₹165 Cr ▲8.6% | ₹152 Cr |
| OPM | 34.0% ▼2.9% | 35.0% ▲0.0% | 35.0% ▲0.0% | 35.0% ▲6.1% | 33.0% ▲0.0% | 33.0% ▼2.9% | 34.0% ▲3.0% | 33.0% |
| Net Profit | ₹173 Cr ▲4.2% | ₹166 Cr ▲3.8% | ₹160 Cr ▲6.0% | ₹151 Cr ▲4.1% | ₹145 Cr ▲3.6% | ₹140 Cr ▲6.9% | ₹131 Cr ▲4.8% | ₹125 Cr |
| EPS (₹) | 22.38 ▲3.8% | 21.56 ▲6.1% | 20.32 ▲1.1% | 20.1 ▲7.1% | 18.76 ▲2.6% | 18.28 ▲6.2% | 17.21 ▲5.5% | 16.31 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.2K Cr ▲12.9% | ₹1.9K Cr ▲14.3% | ₹1.7K Cr ▲15.5% | ₹1.5K Cr ▲15.6% | ₹1.3K Cr ▲19.6% | ₹1.1K Cr ▲22.9% | ₹863 Cr ▲33.0% | ₹649 Cr ▲20.2% | ₹540 Cr ▲34.3% | ₹402 Cr |
| Expenses | ₹1.4K Cr ▲10.8% | ₹1.3K Cr ▲12.7% | ₹1.1K Cr ▲11.4% | ₹1.0K Cr ▲17.3% | ₹874 Cr ▲19.4% | ₹732 Cr ▲21.4% | ₹603 Cr ▲44.6% | ₹417 Cr ▲20.9% | ₹345 Cr ▲25.0% | ₹276 Cr |
| Op. Profit | ₹761 Cr ▲16.9% | ₹651 Cr ▲17.9% | ₹552 Cr ▲24.9% | ₹442 Cr ▲11.9% | ₹395 Cr ▲20.1% | ₹329 Cr ▲26.5% | ₹260 Cr ▲12.1% | ₹232 Cr ▲19.0% | ₹195 Cr ▲56.0% | ₹125 Cr |
| OPM | 35.0% ▲2.9% | 34.0% ▲3.0% | 33.0% ▲10.0% | 30.0% ▼3.2% | 31.0% ▲0.0% | 31.0% ▲3.3% | 30.0% ▼16.7% | 36.0% ▲0.0% | 36.0% ▲16.1% | 31.0% |
| Other Income | ₹116 Cr ▲26.1% | ₹92 Cr ▲39.4% | ₹66 Cr ▲20.0% | ₹55 Cr ▲44.7% | ₹38 Cr ▲65.2% | ₹23 Cr ▼43.9% | ₹41 Cr ▲115.8% | ₹19 Cr ▲46.2% | ₹13 Cr ▲30.0% | ₹10 Cr |
| Interest | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▼50.0% | ₹2 Cr | ₹0 Cr ▼100.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Depreciation | ₹73 Cr ▲10.6% | ₹66 Cr ▲24.5% | ₹53 Cr ▲17.8% | ₹45 Cr ▼4.3% | ₹47 Cr ▲27.0% | ₹37 Cr ▲15.6% | ₹32 Cr ▲39.1% | ₹23 Cr ▲21.1% | ₹19 Cr ▲46.2% | ₹13 Cr |
| PBT | ₹803 Cr ▲18.6% | ₹677 Cr ▲20.0% | ₹564 Cr ▲25.1% | ₹451 Cr ▲16.8% | ₹386 Cr ▲22.9% | ₹314 Cr ▲16.7% | ₹269 Cr ▲18.5% | ₹227 Cr ▲20.7% | ₹188 Cr ▲55.4% | ₹121 Cr |
| Tax % | 19.0% ▼5.0% | 20.0% ▲11.1% | 18.0% ▲12.5% | 16.0% ▼20.0% | 20.0% ▲0.0% | 20.0% ▲0.0% | 20.0% ▼9.1% | 22.0% ▼4.3% | 23.0% ▲9.5% | 21.0% |
| Net Profit | ₹650 Cr ▲20.1% | ₹541 Cr ▲17.4% | ₹461 Cr ▲22.3% | ₹377 Cr ▲22.4% | ₹308 Cr ▲22.7% | ₹251 Cr ▲16.7% | ₹215 Cr ▲21.5% | ₹177 Cr ▲22.1% | ₹145 Cr ▲51.0% | ₹96 Cr |
| EPS (₹) | 84.36 ▲19.6% | 70.56 ▲17.2% | 60.19 ▲21.4% | 49.57 ▲25.3% | 39.56 ▲23.5% | 32.03 ▲12.7% | 28.42 ▲21.7% | 23.35 ▲21.9% | 19.15 ▲51.4% | 12.65 |
| Div Payout | 5.0% ▼37.5% | 8.0% ▲0.0% | 8.0% ▼11.1% | 9.0% ▼10.0% | 10.0% ▲11.1% | 9.0% ▲0.0% | 9.0% ▲0.0% | 9.0% ▼10.0% | 10.0% ▼16.7% | 12.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr ▲0.0% | ₹15 Cr |
| Reserves | ₹3.6K Cr ▲36.3% | ₹2.6K Cr ▲25.7% | ₹2.1K Cr ▲26.4% | ₹1.6K Cr ▲31.7% | ₹1.3K Cr ▲31.2% | ₹954 Cr ▲11.2% | ₹858 Cr ▲47.4% | ₹582 Cr ▲66.8% | ₹349 Cr ▲66.2% | ₹210 Cr |
| Borrowings | ₹5 Cr ▼97.7% | ₹222 Cr ▲1.4% | ₹219 Cr ▼1.4% | ₹222 Cr ▲1.4% | ₹219 Cr ▼6.8% | ₹235 Cr ▲108.0% | ₹113 Cr ▲213.9% | ₹36 Cr ▲3500.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Other Liabilities | ₹454 Cr ▲29.0% | ₹352 Cr ▼7.4% | ₹380 Cr ▲24.6% | ₹305 Cr ▲22.0% | ₹250 Cr ▲57.2% | ₹159 Cr ▲14.4% | ₹139 Cr ▲27.5% | ₹109 Cr ▼19.9% | ₹136 Cr ▲2.3% | ₹133 Cr |
| Total Liabilities | ₹4.0K Cr ▲26.1% | ₹3.2K Cr ▲18.9% | ₹2.7K Cr ▲23.1% | ₹2.2K Cr ▲26.2% | ₹1.7K Cr ▲27.3% | ₹1.4K Cr ▲21.1% | ₹1.1K Cr ▲51.5% | ₹743 Cr ▲48.6% | ₹500 Cr ▲39.7% | ₹358 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹605 Cr ▲10.8% | ₹546 Cr ▲20.5% | ₹453 Cr ▲61.8% | ₹280 Cr ▼2.4% | ₹287 Cr ▼5.9% | ₹305 Cr ▲12.1% | ₹272 Cr ▲19.8% | ₹227 Cr ▲34.3% | ₹169 Cr ▲11.2% | ₹152 Cr |
| CWIP | ₹209 Cr ▲45.1% | ₹144 Cr ▲23.1% | ₹117 Cr ▼47.1% | ₹221 Cr ▲1127.8% | ₹18 Cr ▲28.6% | ₹14 Cr ▼30.0% | ₹20 Cr ▲100.0% | ₹10 Cr ▼33.3% | ₹15 Cr ▲400.0% | ₹3 Cr |
| Investments | ₹859 Cr ▲45.6% | ₹590 Cr ▲56.9% | ₹376 Cr ▲33.8% | ₹281 Cr ▲215.7% | ₹89 Cr ▲709.1% | ₹11 Cr ▼82.0% | ₹61 Cr ▼12.9% | ₹70 Cr ▲48.9% | ₹47 Cr ▲176.5% | ₹17 Cr |
| Other Assets | ₹2.4K Cr ▲23.1% | ₹1.9K Cr ▲10.0% | ₹1.8K Cr ▲24.3% | ₹1.4K Cr ▲5.0% | ₹1.3K Cr ▲30.0% | ₹1.0K Cr ▲33.8% | ₹772 Cr ▲77.1% | ₹436 Cr ▲62.1% | ₹269 Cr ▲44.6% | ₹186 Cr |
| Total Assets | ₹4.0K Cr ▲26.1% | ₹3.2K Cr ▲18.9% | ₹2.7K Cr ▲23.1% | ₹2.2K Cr ▲26.2% | ₹1.7K Cr ▲27.3% | ₹1.4K Cr ▲21.1% | ₹1.1K Cr ▲51.5% | ₹743 Cr ▲48.6% | ₹500 Cr ▲39.7% | ₹358 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹523 Cr ▲21.1% | ₹432 Cr ▲35.8% | ₹318 Cr ▲17.3% | ₹271 Cr ▼19.6% | ₹337 Cr ▲25.3% | ₹269 Cr ▲497.8% | ₹45 Cr ▼45.8% | ₹83 Cr ▲25.8% | ₹66 Cr ▼2.9% | ₹68 Cr |
| Investing CF | ₹-582 Cr ▼74.8% | ₹-333 Cr ▼4.4% | ₹-319 Cr ▼47.7% | ₹-216 Cr ▲42.7% | ₹-377 Cr ▼1156.7% | ₹-30 Cr ▲44.4% | ₹-54 Cr ▲46.0% | ₹-100 Cr ▼44.9% | ₹-69 Cr ▼91.7% | ₹-36 Cr |
| Financing CF | ₹-46 Cr ▼21.1% | ₹-38 Cr ▲0.0% | ₹-38 Cr ▼35.7% | ₹-28 Cr ▲31.7% | ₹-41 Cr ▼70.8% | ₹-24 Cr ▼130.0% | ₹80 Cr ▼11.1% | ₹90 Cr ▲850.0% | ₹-12 Cr ▼71.4% | ₹-7 Cr |
| Net Cash Flow | ₹-106 Cr ▼273.8% | ₹61 Cr ▲256.4% | ₹-39 Cr ▼244.4% | ₹27 Cr ▲133.3% | ₹-81 Cr ▼137.7% | ₹215 Cr ▲207.1% | ₹70 Cr ▼4.1% | ₹73 Cr ▲621.4% | ₹-14 Cr ▼156.0% | ₹25 Cr |
| Free Cash Flow | ₹275 Cr ▲14.1% | ₹241 Cr ▲39.3% | ₹173 Cr ▲121.8% | ₹78 Cr ▼68.3% | ₹246 Cr ▲26.2% | ₹195 Cr ▲709.4% | ₹-32 Cr ▼277.8% | ₹18 Cr ▲0.0% | ₹18 Cr ▼58.1% | ₹43 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 138d ▲16.0% | 119d ▲1.7% | 117d ▲19.4% | 98d ▲7.7% | 91d ▼5.2% | 96d ▼1.0% | 97d ▲7.8% | 90d ▲5.9% | 85d ▲183.3% | 30d |
| Inventory Days | 181d ▲13.8% | 159d ▼13.1% | 183d ▲15.1% | 159d ▲6.7% | 149d ▲7.2% | 139d ▼33.8% | 210d ▲346.8% | 47d ▲6.8% | 44d ▲0.0% | 44d |
| Days Payable | 125d ▲21.4% | 103d ▼11.2% | 116d ▲38.1% | 84d ▼17.6% | 102d ▲50.0% | 68d ▲19.3% | 57d ▼25.0% | 76d ▼47.2% | 144d ▼7.1% | 155d |
| Cash Conv. Cycle | 194d ▲10.9% | 175d ▼4.9% | 184d ▲6.4% | 173d ▲25.4% | 138d ▼16.9% | 166d ▼33.9% | 251d ▲311.5% | 61d ▲481.3% | -16d ▲80.2% | -81d |
| Working Capital Days | 263d ▲51.1% | 174d ▲4.8% | 166d ▲15.3% | 144d ▼12.7% | 165d ▲13.8% | 145d ▼13.2% | 167d ▲60.6% | 104d ▲121.3% | 47d ▲262.1% | -29d |
| ROCE | 25.0% ▼3.8% | 26.0% ▲0.0% | 26.0% ▲0.0% | 26.0% ▼7.1% | 28.0% ▲0.0% | 28.0% ▼15.2% | 33.0% ▼26.7% | 45.0% ▼28.6% | 63.0% ▼7.4% | 68.0% |
Source: Screener.in · Lower days = better efficiency
About Caplin Point Laboratories Limited
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Caplin Point Laboratories Limited share price today?▾
Caplin Point Laboratories Limited (CAPLIPOINT) is currently trading at ₹2,608 on NSE, down 1.56% as of the last market session. Prices update daily after market close on MarketNetra.
Is Caplin Point Laboratories Limited available in F&O (Futures & Options)?▾
Yes, Caplin Point Laboratories Limited (CAPLIPOINT) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Caplin Point Laboratories Limited 52-week high and low?▾
Caplin Point Laboratories Limited's 52-week high is ₹2,700 and the 52-week low is ₹1,500. The current price of ₹2,608 is 3.4% below the 52W high.
What is Caplin Point Laboratories Limited P/E ratio?▾
Caplin Point Laboratories Limited's current P/E ratio is 31. This indicates the market is paying ₹31 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Caplin Point Laboratories Limited options?▾
Caplin Point Laboratories Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade CAPLIPOINT options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.